Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc-Reference-Cited by-同舟云学术

Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc

Published:2016-11-14 Issue:4 Volume:27 Page:614-617
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Ikawa Yuka¹,Hamaguchi Yasuhito¹,Mugii Naoki²,Matsushita Takashi¹,Takehara Kazuhiko¹

Affiliation:

1. Department of Molecular Pathology of Skin, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan and

2. Department of Rehabilitation, Kanazawa University Hospital, Kanazawa, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2016.1250332

Reference22 articles.

1. Classification of systemic sclerosis. Visions and reality**Dedicated to the memory of E. Carwile LeRoy, 1933–2002.

2. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma

3. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

4. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

5. Early Systemic Sclerosis: Analysis of the Disease Course in Patients With Marker Autoantibody and/or Capillaroscopic Positivity

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features of patients with connective tissue disease with anti–human upstream binding factor antibodies: A single‐center retrospective study;The Journal of Dermatology;2024-02-29

2. A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis;Clinical Reviews in Allergy & Immunology;2022-03-07

3. Gastrointestinal Manifestations of Non-GI Disorders;Geriatric Gastroenterology;2021

4. Gastrointestinal Manifestations of Non-GI Disorders;Geriatric Gastroenterology;2020-10-19

5. Up-regulation of IGF-1, RANTES and VEGF in patients with anti-centromere antibody-positive early/mild systemic sclerosis;Modern Rheumatology;2020-02-17